Morphology-engineered alleviation of mycelial aggregation in <i>Streptomyces</i> chassis for potentiated production of secondary metabolites.

Synth Syst Biotechnol · 2025 · PMC12173525 · PMID 40529627

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For example, at 72 h and 96 h, except for MECS06, the engineered strains show highly significant differences when compared to M1146- act .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Morphology-engineered alleviation of mycelial aggregation in &lt;i&gt;Streptomyces&lt;/i&gt; chassis for potentiated production of secondary metabolites.

The sentences

Morphology-engineered alleviation of mycelial aggregation in <i>Streptomyces</i> chassis for potentiated production of secondary metabolites.